TG Therapeutics, Inc. (LON:0VGI)
London
· Delayed Price · Currency is GBP · Price in USD 37.50
-1.05 (-2.72%)
At close: Mar 14, 2025
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of 3.83 billion as of July 9, 2025. Its market cap has increased by 99.67% in one year.
Market Cap
3.83B
Enterprise Value
3.81B
Revenue
299.06M
Ranking
n/a
PE Ratio
126.36
Stock Price
37.50
Market Cap Chart
Since January 10, 2012, TG Therapeutics's market cap has increased from 6.62M to 3.83B, an increase of 57,762.45%. That is a compound annual growth rate of 60.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.34B |
| GSK plc | 57.21B |
| Haleon | 33.35B |
| Smith & Nephew | 9.63B |
| ConvaTec Group | 5.35B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.98B |
| Indivior | 1.43B |